214 related articles for article (PubMed ID: 27793946)
21. Malignant Perivascular Epithelioid Cell Tumor of the Uterus.
Dhanesar GK; Rengarajan H; Chakraborty B
Cureus; 2023 Jul; 15(7):e41685. PubMed ID: 37575749
[TBL] [Abstract][Full Text] [Related]
22. TFE3-associated perivascular epithelioid cell tumor with complete response to mTOR inhibitor therapy: report of first case and literature review.
Purwar R; Soni K; Shukla M; Verma A; Kumar T; Pandey M
World J Surg Oncol; 2022 Mar; 20(1):62. PubMed ID: 35232443
[TBL] [Abstract][Full Text] [Related]
23. Malignant perivascular epithelioid cell tumor of the mesentery: a case report and literature review.
Lai CL; Hsu KF; Yu JC; Chen CJ; Hsieh CB; Chan DC; Li HS; Hsu HM
Onkologie; 2012; 35(3):114-7. PubMed ID: 22414975
[TBL] [Abstract][Full Text] [Related]
24. Systemic Treatments and Molecular Biomarkers for Perivascular Epithelioid Cell Tumors: A Single-institution Retrospective Analysis.
Testa S; Bui NQ; Ganjoo KN
Cancer Res Commun; 2023 Jul; 3(7):1212-1223. PubMed ID: 37448552
[TBL] [Abstract][Full Text] [Related]
25. Update on the imaging of malignant perivascular epithelioid cell tumors (PEComas).
Phillips CH; Keraliya AR; Shinagare AB; Ramaiya NH; Tirumani SH
Abdom Radiol (NY); 2016 Feb; 41(2):368-76. PubMed ID: 26867923
[TBL] [Abstract][Full Text] [Related]
26. Perivascular epithelioid cell tumor (PEComa) of the uterus with aggressive behavior at presentation.
Liu JL; Lin YM; Lin MC; Yeh KT; Hsu JC; Chin CJ
Hematol Oncol Stem Cell Ther; 2009; 2(3):426-30. PubMed ID: 20139058
[TBL] [Abstract][Full Text] [Related]
27. [Uterine malignant perivascular epithelioid cell tumor (PEComa): Two case reports].
El Gani-Mesrar M; Bonneau C; Michenet P; Gourvennec JB; Tabareau-Delalande F
Ann Pathol; 2021 Feb; 41(1):118-122. PubMed ID: 32646778
[TBL] [Abstract][Full Text] [Related]
28. Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms.
Kenerson H; Folpe AL; Takayama TK; Yeung RS
Hum Pathol; 2007 Sep; 38(9):1361-71. PubMed ID: 17521703
[TBL] [Abstract][Full Text] [Related]
29. Neoadjuvant sirolimus for a large hepatic perivascular epithelioid cell tumor (PEComa).
Bergamo F; Maruzzo M; Basso U; Montesco MC; Zagonel V; Gringeri E; Cillo U
World J Surg Oncol; 2014 Feb; 12():46. PubMed ID: 24575738
[TBL] [Abstract][Full Text] [Related]
30. Perivascular Epithelioid Cell Tumor (PEComa) of the Uterine Cervix in a Patient with Tuberous Sclerosis Complex: A Literature Review.
Çelik H; Kefeli M; Çetinkaya M; Yildiz L
Turk Patoloji Derg; 2018; 34(1):82-86. PubMed ID: 25110244
[TBL] [Abstract][Full Text] [Related]
31. PEComa: morphology and genetics of a complex tumor family.
Thway K; Fisher C
Ann Diagn Pathol; 2015 Oct; 19(5):359-68. PubMed ID: 26144278
[TBL] [Abstract][Full Text] [Related]
32. An unresectable malignant perivascular epithelioid cell tumor resistant to multiple combined chemotherapies: a unique case report.
Peng J; Yu B; Wang J; Hong X; Xu Y; Cai S
J Pediatr Hematol Oncol; 2010 May; 32(4):e136-8. PubMed ID: 20051914
[TBL] [Abstract][Full Text] [Related]
33. VEGFR Inhibitors for Uterine Metastatic Perivascular Epithelioid Tumors (PEComa) Resistant to mTOR Inhibitors. A Case Report and Review of Literature.
Liapi A; Mathevet P; Herrera FG; Hastir D; Sarivalasis A
Front Oncol; 2021; 11():641376. PubMed ID: 33842348
[TBL] [Abstract][Full Text] [Related]
34. Uterine PEComa with aggressive behavior: A review with an additional case of spontaneous vaginal expulsion.
Gentile M; Zinna M; Zanella C; Costanza A; Dalfior D; Sina S; Greco F; Fiorica F; Colombari R; Catapano P; Bonetti A; Remo A
Pathol Res Pract; 2020 Jun; 216(6):152991. PubMed ID: 32527449
[TBL] [Abstract][Full Text] [Related]
35. The Impact of TSC-1 and -2 Mutations on Response to Therapy in Malignant PEComa: A Multicenter Retrospective Analysis.
Liu L; Dehner C; Grandhi N; Lyu Y; Borcherding DC; Chrisinger JSA; Zhang X; Luo J; Tao Y; Parkes A; Bui NQ; Davis EJ; Milhem MM; Monga V; Weiss M; Tine BV; Hirbe AC
Genes (Basel); 2022 Oct; 13(11):. PubMed ID: 36360169
[TBL] [Abstract][Full Text] [Related]
36. Perivascular epitheliod cell tumors: Study of three gynecological cases.
Nicolás I; Fusté P; Saco A; Ordi J; Torné A
Med Clin (Barc); 2019 Jul; 153(2):83-87. PubMed ID: 30827678
[TBL] [Abstract][Full Text] [Related]
37. Uterine perivascular epithelioid cell neoplasms (PEComas): report of two cases and literature review.
Cossu A; Paliogiannis P; Tanda F; Dessole S; Palmieri G; Capobianco G
Eur J Gynaecol Oncol; 2014; 35(3):309-12. PubMed ID: 24984548
[TBL] [Abstract][Full Text] [Related]
38. Rapid and Durable Response With Nab-Sirolimus After Everolimus Failure in a Patient With Perivascular Epithelioid Cell Tumors (PEComas) of the Uterus.
Kopparthy P; Murphy M
Cureus; 2021 May; 13(5):e14951. PubMed ID: 34123648
[TBL] [Abstract][Full Text] [Related]
39. Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex.
MacKeigan JP; Krueger DA
Neuro Oncol; 2015 Dec; 17(12):1550-9. PubMed ID: 26289591
[TBL] [Abstract][Full Text] [Related]
40. Uterine Perivascular Epithelioid Cell Tumor (PEComa) in A 56-year-Old Woman.
Aljehani A; Abu-Zaid A; Albadawi MI; Alomar O; Alkushi A
Gulf J Oncolog; 2022 Jan; 1(38):86-89. PubMed ID: 35156650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
